| Validation of the Sickle Cell Disease Pain Burden Interview (NCT00804362) | Connecticut Children's Medical Center | 2008-12-01 |
| Intravenous Gammaglobulin for Sickle Cell Pain Crises (NCT01757418) | Albert Einstein College of Medicine | 2008-11-01 |
| Evaluation of Non-invasive Endothelial Function in Children Sickle by Vascular Ultrasound (NCT02829580) | University Hospital, Toulouse | 2008-09-01 |
| Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells (NCT00730314) | Children's Hospital Los Angeles | 2008-08-01 |
| Evaluating the Safety and Effectiveness of Bone Marrow Transplants in Children With Sickle Cell Disease (BMT CTN 0601) (NCT00745420) | Medical College of Wisconsin | 2008-08-01 |
| Screening for Subjects to Participate in Studies of Blood Disorders (NCT00695123) | National Heart, Lung, and Blood Institute (NHLBI) | 2008-07-03 |
| TRF-1101 Assessment in Sickle Cell Disease (NCT00773890) | TRF Pharma, Inc | 2008-07-01 |
| Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders (NCT00489281) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2008-06-23 |
| Sildenafil for Treatment of Priapism in Men With Sickle Cell Anemia (NCT00940901) | Johns Hopkins University | 2008-06-01 |
| Low-Dose Ketamine Infusion for Children With Sickle Cell Disease-Related Pain (NCT00595530) | Connecticut Children's Medical Center | 2008-03-04 |
| Pilot Study for Patients With Poor Response to Deferasirox (NCT00749515) | Boston Children's Hospital | 2008-03-01 |
| Kidney Transplantation in Patients With Sickle Cell Disease (NCT00663507) | Emory University | 2008-03-01 |
| Secondary Pulmonary Hypertension in Adults With Sickle Cell Anemia (NCT00011648) | National Heart, Lung, and Blood Institute (NHLBI) | 2008-02-19 |
| Assessing Function in Pediatric Patients With Sickle Cell Disease (NCT00590148) | Connecticut Children's Medical Center | 2008-01-01 |
| Methadone in Pediatric and Adult Sickle Cell Patients (NCT00761085) | Washington University School of Medicine | 2008-01-01 |
| Blood Sampling for Research Related to Sickle Cell Disease (NCT00542230) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2007-11-07 |
| Comparison of Patient Controlled Analgesia (PCA) Versus Bolus Narcotic Therapy for the Treatment of Vaso-Occlusive Crisis (VOC) (NCT00711698) | Johns Hopkins University | 2007-09-01 |
| Niacin to Improve Blood Flow in People With Sickle Cell Disease (NCT00508989) | National Heart, Lung, and Blood Institute (NHLBI) | 2007-07-24 |
| Transfusion Alternatives Pre-operatively in Sickle Cell Disease (TAPS) (NCT00512577) | NHS Blood and Transplant | 2007-07-01 |
| Sildenafil Therapy for Pulmonary Hypertension and Sickle Cell Disease (NCT00492531) | National Heart, Lung, and Blood Institute (NHLBI) | 2007-06-01 |
| Phase 1 Study of Zoledronic Acid in Sickle Cell Disease (NCT00639392) | Virginia Commonwealth University | 2007-06-01 |
| Simvastatin (Zocor) Therapy in Sickle Cell Disease (NCT00508027) | UCSF Benioff Children's Hospital Oakland | 2007-06-01 |
| A Phase 2 Study of the Effects of 6R-BH4 in Subjects With Sickle Cell Disease (NCT00445978) | BioMarin Pharmaceutical | 2007-05-01 |
| Hypnosis to Manage Pain and Symptoms in Patients With Sickle Cell Disease (NCT00393250) | National Institutes of Health Clinical Center (CC) | 2007-04-30 |
| Evaluation of the Prevalence of Pulmonary Hypertension in Adult Patients With Sickle Cell Disease (NCT00434902) | Assistance Publique - Hôpitaux de Paris | 2007-02-01 |
| IMPACTS Trial: Investigation of the Modulation of Phospholipase in Acute Chest Syndrome (NCT00434473) | Anthera Pharmaceuticals | 2006-12-01 |
| Pain Management Protocol for Pediatric Sickle Cell Disease (NCT00386048) | University of South Carolina | 2006-11-01 |
| Assessment of Opioid Analgesia in Sickle Cell (NCT00513864) | Children's National Research Institute | 2006-11-01 |
| L-Arginine and Sickle Cell Disease (NCT01142219) | Hospital de Clinicas de Porto Alegre | 2006-09-01 |
| Autologous Bone Marrow Stem Cells for Chronic Leg Ulcer Treatment in Sickle Cell Disease (NCT02619734) | Federal University of Bahia | 2006-08-01 |
| Autologous Bone Marrow Stem Cell Transplantation for Osteonecrosis in Sickle Cell Disease (NCT02448121) | Federal University of Bahia | 2006-08-01 |
| Hydroxyurea for Children and Young Adults With Sickle Cell Disease and Pulmonary Hypertension (NCT00350844) | Ann & Robert H Lurie Children's Hospital of Chicago | 2006-07-01 |
| The Link Between Anemia and Deficits in Memory and Attention in Individuals With Sickle Cell Disease (NCT00451919) | National Heart, Lung, and Blood Institute (NHLBI) | 2006-07-01 |
| Pulmonary Hypertension in Patients With Sickle Cell Disease in Nigeria (NCT00367523) | National Heart, Lung, and Blood Institute (NHLBI) | 2006-06-15 |
| Ameliorating Attention Problems in Children With Sickle Cell Disease (SCD) (NCT01411280) | Temple University | 2006-06-01 |
| Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease (NCT00305175) | St. Jude Children's Research Hospital | 2006-03-03 |
| Effectiveness of Laying-on-of-hands for Sickle Cell Disease (NCT01518218) | MOA Health Science Foundation | 2006-03-01 |
| A Study Evaluating the Long-Term Safety of ICA-17043 in Sickle Cell Disease Patients With or Without Hydroxyurea Therapy (NCT00294541) | Icagen | 2006-02-01 |
| SALT: Alternative Donor Bone Marrow and Cord Blood Transplantation for High Risk Sickle Cell Disease (NCT00257543) | Emory University | 2006-01-01 |
| Hydroxyurea and Erythropoietin to Treat Sickle Cell Anemia (NCT00270478) | National Heart, Lung, and Blood Institute (NHLBI) | 2005-12-21 |
| Steroid Treatment for Sickle Cell Pain Crisis (NCT00263562) | Baylor College of Medicine | 2005-12-01 |
| Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload (NCT00235391) | Novartis Pharmaceuticals | 2005-10-01 |
| Analysis of T-Cell Immune Reconstitution Following Allogeneic Hematopoietic BMT for Severe SCD (NCT00228631) | Emory University | 2005-09-01 |
| Study of Blood Platelets in Sickle Cell Disease (NCT00226083) | Rockefeller University | 2005-08-01 |
| Kid Cards: Teaching Kids About Medicines (NCT00127543) | Children's Mercy Hospital Kansas City | 2005-08-01 |
| Bone Marrow Transplantation, Hemoglobinopathies, SCALLOP (NCT00578344) | Tami D. John | 2005-07-01 |
| Curative Versus Disease-Modifying Therapies in Children With Severe Sickle Cell Disease (NCT01369160) | Emory University | 2005-05-01 |
| Study of Deferasirox Relative to Subcutaneous Deferoxamine in Sickle Cell Disease Patients (NCT00110617) | Novartis Pharmaceuticals | 2005-05-01 |
| Inhaled Nitric Oxide for Pediatric Painful Sickle Crisis (NCT00142051) | Boston Children's Hospital | 2005-04-01 |
| Haploidentical Stem Cell Transplant for Patients With Sickle Cell Disease and Prior Stroke or Abnormal Transcranial Ultrasound (NCT00152113) | St. Jude Children's Research Hospital | 2005-04-01 |
| Codeine in Sickle Cell Disease (NCT00174538) | PriCara, Unit of Ortho-McNeil, Inc. | 2005-03-01 |
| Aspirin Prophylaxis in Sickle Cell Disease (NCT00178464) | University of Rochester | 2005-03-01 |
| A Pilot Study of Chronic Red Blood Cell Transfusion in Sickle Cell Disease-Associated Pulmonary Hypertension (NCT00850369) | University of North Carolina, Chapel Hill | 2005-02-01 |
| A Stratified Sickle Event Randomized Trial (ASSERT) (NCT00102791) | Icagen | 2005-02-01 |
| Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies (NCT00777231) | Talaris Therapeutics Inc. | 2005-01-01 |
| Stem Cell Transplant in Sickle Cell Disease and Thalassemia (NCT00408447) | Columbia University | 2004-09-01 |
| Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias (NCT00061568) | National Heart, Lung, and Blood Institute (NHLBI) | 2004-07-16 |
| Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO). (NCT01090323) | Novartis Pharmaceuticals | 2004-07-01 |
| Pilot Study on the Effects of Intravenous Ketamine on Acute Pain Crisis in Patients With Sickle Cell Disease (NCT00252122) | Children's Hospital of Philadelphia | 2004-06-01 |
| Allogeneic Stem Cell Transplantation Following Chemotherapy in Patients With Hemoglobinopathies (NCT00153985) | Dana-Farber Cancer Institute | 2004-03-01 |
| Atorvastatin Therapy to Improve Endothelial Function in Sickle Cell Disease (NCT00072826) | National Institutes of Health Clinical Center (CC) | 2003-11-04 |
| A Rehabilitation Program in Children With Sickle Cell Disease and Cognitive Deficits: a Pilot Study (NCT00895154) | Washington University School of Medicine | 2003-09-01 |
| Home Based Massage and Relaxation for Sickle Cell Pain (NCT00066079) | National Center for Complementary and Integrative Health (NCCIH) | 2003-08-01 |
| Blood Collection for Research Related to Certain Diseases Involving Blood Vessels (NCT00047996) | National Heart, Lung, and Blood Institute (NHLBI) | 2002-11-04 |
| Stem Cell Transplant for Hemoglobinopathy (NCT00176852) | Masonic Cancer Center, University of Minnesota | 2002-06-01 |
| A Pilot Study of HSCT for Patients With High-risk Hemoglobinopathy Using a Nonmyeloablative Preparative Regimen (NCT00427661) | University of Pittsburgh | 2002-06-01 |
| A Study of the Efficacy and Safety of ICA-17043 (With or Without Hydroxyurea) in Patients With Sickle Cell Anemia. (NCT00040677) | Icagen | 2002-02-01 |
| Collection and Storage of Umbilical Cord Stem Cells for Treatment of Sickle Cell Disease (NCT00012545) | National Heart, Lung, and Blood Institute (NHLBI) | 2001-11-01 |
| Stem Cell Transplantation With Identical Donors for Patients With Sickle Cell Disease (NCT00186810) | St. Jude Children's Research Hospital | 1992-12-01 |
| Managed Access Programs for SEG101, Crizanlizumab (NCT03720626) | Novartis Pharmaceuticals | |
| Expanded Access to Voxelotor for Patients With Sickle Cell Disease Who Have No Alternative Treatment Options (NCT03943615) | Pfizer | |
| PK and PD Responses to Oral L-Citrulline in Patients With Sickle Cell Disease (NCT00343954) | Angiogenix | |
| Expanded Access to CD34+ Selection Utilizing Miltenyi CliniMACS Prodigy® for Patients Receiving Peripheral Blood Stem Cell Transplantations and Stem Cell Boosts (NCT06731036) | University of Florida | |
| Expanded Access Protocol for Gene Therapy Utilizing shmiR Lentivirus Vector to Induce Fetal Hemoglobin in Sickle Cell Disease (NCT07640815) | David Williams | |